Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014 May;25(5):869-71.
doi: 10.1681/ASN.2014020174. Epub 2014 Apr 10.

Endothelin antagonists in diabetic nephropathy: back to basics

Affiliations
Editorial

Endothelin antagonists in diabetic nephropathy: back to basics

Kiran Chandrashekar et al. J Am Soc Nephrol. 2014 May.
No abstract available

Keywords: cell signaling; chronic kidney disease; diabetic; endothelin antagonists; glomerulosclerosis; nephropathy; podocyte.

PubMed Disclaimer

Comment on

References

    1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415, 1988 - PubMed
    1. Barton M, Yanagisawa M: Endothelin: 20 years from discovery to therapy. Can J Physiol Pharmacol 86: 485–498, 2008 - PubMed
    1. Lüscher TF, Barton M: Endothelins and endothelin receptor antagonists: Therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102: 2434–2440, 2000 - PubMed
    1. Speed JS, Pollock DM: Endothelin, kidney disease, and hypertension. Hypertension 61: 1142–1145, 2013 - PMC - PubMed
    1. Kitamura K, Tanaka T, Kato J, Eto T, Tanaka K: Regional distribution of immunoreactive endothelin in porcine tissue: Abundance in inner medulla of kidney. Biochem Biophys Res Commun 161: 348–352, 1989 - PubMed